People | Locations | Statistics |
---|---|---|
Naji, M. |
| |
Motta, Antonella |
| |
Aletan, Dirar |
| |
Mohamed, Tarek |
| |
Ertürk, Emre |
| |
Taccardi, Nicola |
| |
Kononenko, Denys |
| |
Petrov, R. H. | Madrid |
|
Alshaaer, Mazen | Brussels |
|
Bih, L. |
| |
Casati, R. |
| |
Muller, Hermance |
| |
Kočí, Jan | Prague |
|
Šuljagić, Marija |
| |
Kalteremidou, Kalliopi-Artemi | Brussels |
|
Azam, Siraj |
| |
Ospanova, Alyiya |
| |
Blanpain, Bart |
| |
Ali, M. A. |
| |
Popa, V. |
| |
Rančić, M. |
| |
Ollier, Nadège |
| |
Azevedo, Nuno Monteiro |
| |
Landes, Michael |
| |
Rignanese, Gian-Marco |
|
Turza, Alexandru
National Institute for Research and Development of Isotopic and Molecular Technologies
in Cooperation with on an Cooperation-Score of 37%
Topics
Publications (6/6 displayed)
- 2023Development of a Bilayer Tablet by Fused Deposition Modeling as a Sustained-Release Drug Delivery Systemcitations
- 2022Structural studies of various olmesartan solvatescitations
- 2021New solvates and a salt of the anti-HIV compound etravirinecitations
- 2020Photocatalytic and Electrocatalytic Properties of NGr-ZnO Hybrid Materialscitations
- 2020Exploring the Polymorphism of Drostanolone Propionatecitations
- 2019Graphene/silver nanoparticles‐based surface‐enhanced Raman spectroscopy detection platforms: Application in the study of DNA molecules at low pHcitations
Places of action
Organizations | Location | People |
---|
article
New solvates and a salt of the anti-HIV compound etravirine
Abstract
<jats:p>Four new solvates of the anti-HIV compound etravirine [systematic name: 4-({6-amino-5-bromo-2-[(4-cyanophenyl)amino]pyrimidin-4-yl}oxy)-3,5-dimethylbenzonitrile, C<jats:sub>20</jats:sub>H<jats:sub>15</jats:sub>BrN<jats:sub>6</jats:sub>O] with dimethyl sulfoxide (C<jats:sub>2</jats:sub>H<jats:sub>6</jats:sub>OS, two distinct monosolvates), 1,4-dioxane (C<jats:sub>4</jats:sub>H<jats:sub>8</jats:sub>O<jats:sub>2</jats:sub>, the 0.75-solvate) and <jats:italic>N</jats:italic>,<jats:italic>N</jats:italic>-dimethylacetamide (C<jats:sub>4</jats:sub>H<jats:sub>9</jats:sub>NO, the monosolvate), which exhibit conversion to the same anhydrous etravirine phase upon desolvation, and a stable etravirinium oxalate salt {6-amino-5-bromo-4-(4-cyano-2,6-dimethylphenoxy)-2-[(4-cyanophenyl)amino]pyrimidin-1-ium hemioxalate, C<jats:sub>20</jats:sub>H<jats:sub>16</jats:sub>BrN<jats:sub>6</jats:sub>O<jats:sup>+</jats:sup>·0.5C<jats:sub>2</jats:sub>O<jats:sub>4</jats:sub><jats:sup>2−</jats:sup>} were obtained. The crystal structures were solved by single-crystal X-ray diffraction and analyzed by powder X-ray diffraction, and the intermolecular interactions were explored by Hirshfeld surface analysis. Lattice energies were evaluated using the atom–atom force field Coulomb–London–Pauli (AA CLP) approximation, which distributes the total energy as four separate contributions: Coulombic, polarization, dispersion and repulsion. The formation of the solvates and the oxalate salt was further characterized by thermal analysis and IR spectroscopy.</jats:p>